ADAR1 Capital Management »

EXACT Sciences Corporation shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of EXACT Sciences Corporation (EXAS) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in EXACT Sciences Corporation

Tip: Access up to 7 years of quarterly data

All positions including EXACT Sciences Corporation held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in EXACT Sciences Corporation by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $117k 1.7k 69.06

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding EXACT Sciences Corporation

Vanguard Group
Capital World Investors
BlackRock
BlackRock
State Street Corporation
Jpmorgan Chase & Co
William Blair Investment Management
Artisan Partners Limited Partnership
T. Rowe Price Investment Management
T. Rowe Price Associates
Geode Capital Management
Champlain Investment Partners
Holocene Advisors
Macquarie Group
CAM Group Holding A/S

View all funds holding EXACT Sciences Corporation